Usana Health Sciences Inc
USNA
Market Cap$610.28M
Close$
$53.14
62.2% upside
Current Fair Value
62.2% upsideUndervalued by 62.2% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $610.28 Million |
|---|---|
| Enterprise Value | $453.67 Million |
| Dividend Yield | $0 (0%) |
| Earnings per Share | $2.2 |
| Beta | 0.64 |
| Outstanding Shares | 19,049,000 |
Return
| Return on Equity | - |
|---|---|
| Return on Assets | - |
| Return on Invested Capital | - |
Valuation & Multiples
| P/E Ratio | 17.87 |
|---|---|
| PEG | -41.43 |
| Price to Sales | 0.73 |
| Price to Book Ratio | 1.09 |
| Enterprise Value to Revenue | 0.52 |
| Enterprise Value to EBIT | 6.35 |
| Enterprise Value to Net Income | 12 |
| Total Debt to Enterprise | 0.05 |
| Debt to Equity | 0.04 |
Revenue Sources
No data
Insider Trades
ESG Score
No data
About Usana Health Sciences Inc
CEO: Kevin Guest